Lugo, Spain

Asteria Luzardo Álvarez

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis), Servizo Galego De Saude, Universidade De Santiago De Compostela. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asteria Luzardo Álvarez. Retrieved from https://idiyas.com/inventor/asteria-luzardo-alvarez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asteria Luzardo Álvarez: Innovator in Nanostructured Lipid Systems

Introduction

Asteria Luzardo Álvarez is a prominent inventor based in Lugo, Spain. She has made significant contributions to the field of enzyme replacement therapy, particularly in the treatment of lysosomal diseases. Her innovative approach focuses on the development of nanostructured lipid systems, which have the potential to revolutionize therapeutic applications.

Latest Patents

Asteria holds a patent for her invention titled "Nanostructure Lipid System." This invention relates to systems for administering enzymes or other proteins, specifically designed for use in enzyme replacement therapy. The patent encompasses the preparation of a composition based on nanostructured lipid systems and its application in manufacturing therapeutic products. Asteria's work in this area is crucial for advancing treatments for lysosomal diseases.

Career Highlights

Throughout her career, Asteria has been associated with esteemed institutions such as the Universidade De Santiago De Compostela and the Servizo Galego De Saude. Her work in these organizations has allowed her to collaborate with other experts in the field and contribute to significant advancements in medical technology.

Collaborations

Asteria has worked alongside notable colleagues, including José Víctor Álvarez González and Francisco Javier Otero Espinar. These collaborations have enriched her research and expanded the impact of her innovations in enzyme replacement therapy.

Conclusion

Asteria Luzardo Álvarez is a trailblazer in the development of nanostructured lipid systems for enzyme replacement therapy. Her contributions are paving the way for new therapeutic options for patients with lysosomal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…